Skip to main content
    B

    Biocardia Inc (BCDA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.79
    -0.00 (-0.24%)

    Market Cap: $12.58M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Biocardia Inc (BCDA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Biocardia (BCDA) has a market cap of $12.58M and an enterprise value of $10.36M. It holds $2.22M more cash than debt, 17.68% of its market cap.

    Total Valuation

    Enterprise value is 17.68% below the market cap, as cash exceeds debt.

    Market Cap$12.58M
    Enterprise Value$10.36M
    Latest price (Nov 17, 2026)$0.79

    Key Dates

    The next earnings report is expected on Mar 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 22, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 25.16% in the quarter ended Sep 30, 2026 and grew 131.36% a year over 2 years.

    Shares Outstanding15.14M
    Shares Change (QoQ)+25.16%
    Share Count Growth (2Y CAGR)+131.36%

    Price Statistics

    The stock is down 35.92% over 52 weeks and trades 20.20% below its 50-day average.

    Beta (1Y)0.57
    52-Week Change-35.92%
    1-Month Change-12.18%
    3-Month Change-20.46%
    6-Month Change-17.11%
    5-Year Change-97.95%
    10-Year Change-96.04%
    Total Return (1Y)-35.92%
    Total Return (3Y CAGR)-58.22%
    Total Return (5Y CAGR)-52.55%
    Max Drawdown (1Y)-47.54%
    Max Drawdown (3Y)-92.86%
    Sharpe Ratio (1Y)-0.73
    Correlation with SPY (1Y)0.11
    50-Day Average$0.99
    200-Day Average$1.05
    52-Week Range$0.66 to $1.50
    RSI (14 Days)35.6
    Average Volume (20 Days)90.04K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.11x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.11x
    Quick Ratio1.11x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -918.92% and return on assets is -249.85% over the last 12 months.

    Return on Equity (ROE)-918.92%
    Return on Assets (ROA)-249.85%

    Scores

    BCDA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Gross Profit-$185.00K
    Operating Income-$7.74M
    Pretax Income-$7.07M
    Net Income-$7.67M
    Reported EPS (TTM)-$0.52

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 27.20% of the $3.07M in total assets.

    Cash and Equivalents$2.22M
    Total Debt$0
    Net Cash$2.22M
    Net Cash Per Share$0.15
    Working Capital$240.00K
    Shareholder Equity$835.00K
    Book Value Per Share$0.06
    Total Assets$3.07M
    Total Liabilities$2.24M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$7.61M
    FCF Per Share-$0.50
    Depreciation and Amortization$553.00K
    Share Repurchases$433.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    BCDA does not pay a dividend.

    Buyback Yield-40.87%
    Shareholder Yield-40.87%

    Stock Splits

    The last split was a 1-for-15 reverse split on May 30, 2024.

    Last Split DateMay 30, 2024
    Split TypeReverse split
    Split Ratio1:15

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About BCDA

    What is BCDA's market cap?

    Biocardia has a market cap of $12.58M. Its enterprise value, which adds debt and subtracts cash, is $10.36M.

    How many shares of BCDA are outstanding?

    Biocardia has 15.14M shares outstanding.

    Does BCDA pay a dividend?

    No. Biocardia does not pay a dividend.

    How much debt does BCDA have?

    Biocardia has $0 of total debt and $2.22M of cash and equivalents, a net cash position of $2.22M.